SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-241900
Filing Date
2012-05-21
Accepted
2012-05-21 16:58:06
Documents
8
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d355328d10q.htm 10-Q 389534
2 SECTION 302 CEO AND CFO CERTIFICATION d355328dex311.htm EX-31.1 9981
3 SECTION 906 CEO AND CFO CERTIFICATION d355328dex321.htm EX-32.1 4646
  Complete submission text file 0001193125-12-241900.txt   1994016

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ljpc-20120331.xml EX-101.INS 327439
5 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20120331.xsd EX-101.SCH 10746
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20120331_cal.xml EX-101.CAL 19939
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20120331_lab.xml EX-101.LAB 83220
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20120331_pre.xml EX-101.PRE 51852
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 12859467
SIC: 2836 Biological Products, (No Diagnostic Substances)